Complexes of plasmid DNA with basic domain 47-57 of the HIV-1 Tat protein are transferred to mammalian cells by endocytosis-mediated pathways.
Arginine-rich peptides, penetratins, as part of a number of cellular and viral proteins, can penetrate across plasma membrane directly, without participation of endocytosis. We show that one of penetratins, the basic domain 47-57 of human immunodeficiency virus, type 1, transcription factor Tat (Tat peptide), is able to interact with plasmid DNA electrostatically. These interactions result in formation of polyelectrolytic complexes at various negative/positive charge ratios of plasmid DNA and Tat peptide. Plasmid DNA is capable of binding to Tat peptide up to 1.7-fold excess of the complex positive charge. The DNA-Tat complexes can be used for delivery of plasmid DNA into mammalian cells. Transfection efficacy of cultured cells by DNA-Tat complexes is stimulated by free Tat peptide, most likely because it protects DNA-Tat complexes from disruption by anionic proteoglycans of cellular surface. Our data strongly argue in favor of the endocytosis-dependent mechanism of DNA-Tat complex uptake by mammalian cells similarly to internalization of complexes of plasmid DNA with other polycationic carriers. Moreover, different cell lines use different endocytosis-mediated pathways for DNA-Tat complex internalization. Intravenous injections to mice of DNA-Tat complexes in comparison with injections of naked DNA showed an inhibitory effect of DNA-Tat complex positive charge on expression of transferred gene. A low level of foreign gene expression in the liver of mice injected intravenously with positively charged DNA-Tat complexes is accounted for by inactivation of DNA-Tat complexes in the bloodstream due to their interactions with serum albumin. These data should be taken into account in an attempt to develop versatile gene delivery systems based on penetratin application for human disease therapy.
Ignatovich
Irina A
IA
Department of Cell Biology, St. Petersburg State University, 199034 St. Petersburg, Russia.
Dizhe
Ella B
EB
Pavlotskaya
Anna V
AV
Akifiev
Boris N
BN
Burov
Sergey V
SV
Orlov
Sergey V
SV
Perevozchikov
Andrej P
AP
D000595:Amino Acid Sequence; D024361:Amino Acids, Basic; D000818:Animals; D016632:Apolipoprotein A-I / Q000235:genetics; D002352:Carrier Proteins; D002460:Cell Line; D057846:Cell-Penetrating Peptides; D016503:Drug Delivery Systems; D004705:Endocytosis; D015696:Gene Products, tat / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000378:metabolism / Q000493:pharmacokinetics; D006801:Humans; D007700:Kinetics; D051379:Mice; D010957:Plasmids / Q000378:metabolism / Q000493:pharmacokinetics; D011485:Protein Binding; D019810:Sodium Azide / Q000494:pharmacology; D001616:beta-Galactosidase / Q000235:genetics
D024361:Amino Acids, Basic; D016632:Apolipoprotein A-I; D002352:Carrier Proteins; D057846:Cell-Penetrating Peptides; D015696:Gene Products, tat; D019810:Sodium Azide; C414409:penetratin; D001616:beta-Galactosidase